Physicians Academy
Established in December 2006 by the Kashmir Academy Of Private Physicians
Table Of Contents
Editorial :
 Bacterial Infections in Patients with Leukemia
Article 1 :
 What after a Suicide Attempt?
Article 2 :
 Neglected Child with severe Bronchopneumonia
Picture of The Month :
 Picture of The Month November 2017
Drug Update :
 VELCADE (Bortezomib)
Abstracts from Other Journals :
 Abstracts from Other Journals-November 2017

Locations of visitors to this page
 
     
 
 
Nov 2017 (Volume -11Number -11)

Editorial
Bacterial Infections in Patients with Leukemia
Shamweel Ahmad, PhD
Rapid Response  |  Back

Bacterial Infections in Patients with Leukemia

Shamweel Ahmad, PhD

Despite significant advances in supportive care, infectious complications continue to be a significant cause of morbidity and mortality in patients with leukemia. The implementation of empiric antibiotic therapy in patients with febrile neutropenia led to dramatic reduction in mortality and was hailed as a turning point in cancer treatment.  Nonetheless, the development of more effective and dose intensive salvage chemotherapy regimens, incorporation of monoclonal antibodies, use of consolidation and maintenance strategies, and increased use of indwelling venous catheters have increased susceptibility to infections and changed the spectrum of infections in patients with leukemia. Specifically, multidrug resistant organisms, as well as those previously considered innocuous have emerged. Even under the optimal circumstances i.e. timely diagnosis and implementation of appropriate therapy, infections in leukemia remain a therapeutic challenge.

The most common bacterial pathogen in the 1960s in neutropenic patients was Staphylococcus aureus. However, presumably due to the widespread use of methicillin, fatal staphylococcal infection rates dropped from 23.5% in 1954 to 3.1% in 1963 according to a ten year review of National Cancer Institute data. This success was dampened in the late 1960s and early 1970s by the emergence of aerobic gram-negative bacilli such as Klebsiella pneumoniae, Enterobacter, E. coli, Pseudomonas and other enteric organisms such as Enterococci and the anerobes. Cephalothin, a first-generation cephalosporin, led to improved outcomes with these infections. This period marked the emergence of Pseudomonas aeruginosa as a major pathogen associated with high mortality rates in this population.

Bloodstream infections (BSI) are commonly associated with mucositis, cellulitis, pneumonia, neutropenic enterocolitis, invasive fungal disease and central venous catheters. The clinical presentations of BSI may vary from bacteremia to fulminant shock. It should be emphasized that gram-negative organisms continue to dominate the scene as the most frequent pathogens causing infections in febrile neutropenic patients. Apart from BSI, other sites of infection include the respiratory tract, skin and soft tissue, gastrointestinal and genitourinary tract, in order of frequency.

Author Information: Dr. Shamweel Ahmad is Professor of Medical Microbiology and Consultant Microbiologist, Department of Clinical Laboratory Sciences, College of Medical Sciences, Prince Sattam Bin Abdulaziz University, Kingdom of Saudi Arabia. He is also Member: Saudi Advisory Board on MRSA. Expert/Reviewer/Item writer: Saudi Commission for Health Specialties.

Email: drshamweel@hotmail.com

Tel (O): +966115886341

To Get This Article in PDF CLICK HERE

Rapid Response  |  Back
 
 
 
 
 
  Listed in Directory Of Open Access Journals (DOAJ).   ||    Google Scholar   ||    INFOPORT   ||    OAJSE  
  Copyright © 2017 Physicians Academy (ISSN : 0973-998X). All rights reserved.  |   Developed By: DZ International